Last: | $43.555 |
---|---|
Change Percent: | 0.47% |
Open: | $43.58 |
Close: | $43.35 |
High: | $43.6 |
Low: | $43.34 |
Volume: | 307,434 |
Last Trade Date Time: | 05/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$43.555 | $43.58 | $43.35 | $43.6 | $43.34 | 307,434 | 05-03-2024 |
$43.35 | $42.9 | $43.35 | $43.515 | $42.75 | 5,943,545 | 05-02-2024 |
$42.57 | $42.7 | $42.57 | $42.84 | $42.275 | 4,686,149 | 05-01-2024 |
$41.44 | $41.75 | $41.44 | $42.03 | $41.42 | 2,998,742 | 04-30-2024 |
$41.61 | $41.66 | $41.61 | $42 | $41.5 | 4,043,333 | 04-29-2024 |
$41.11 | $40.95 | $41.11 | $41.3125 | $40.87 | 2,730,464 | 04-26-2024 |
$40.91 | $41.06 | $40.91 | $41.11 | $40.805 | 3,015,243 | 04-25-2024 |
$40.86 | $41.2 | $40.86 | $41.24 | $40.635 | 1,673,690 | 04-24-2024 |
$41.24 | $40.66 | $41.24 | $41.26 | $40.6 | 2,289,896 | 04-23-2024 |
$40.59 | $39.99 | $40.59 | $40.755 | $39.96 | 3,800,880 | 04-22-2024 |
$39.75 | $39.37 | $39.75 | $39.76 | $39.37 | 1,623,882 | 04-19-2024 |
$39.27 | $39.39 | $39.27 | $39.5 | $39.155 | 2,636,945 | 04-18-2024 |
$39.6 | $39.72 | $39.6 | $39.85 | $39.44 | 3,208,339 | 04-17-2024 |
$39.95 | $40.02 | $39.95 | $40.23 | $39.72 | 2,422,869 | 04-16-2024 |
$40.5 | $40.9 | $40.5 | $41.055 | $40.44 | 3,373,753 | 04-15-2024 |
$40.66 | $40.96 | $40.66 | $40.97 | $40.49 | 5,264,697 | 04-12-2024 |
$40.8 | $41 | $40.8 | $41.25 | $40.68 | 2,903,779 | 04-11-2024 |
$40.69 | $40.62 | $40.69 | $40.75 | $40.485 | 4,370,362 | 04-10-2024 |
$40.88 | $40.89 | $40.88 | $40.9589 | $40.67 | 3,191,316 | 04-09-2024 |
$40.85 | $41.08 | $40.85 | $41.08 | $40.821 | 1,856,137 | 04-08-2024 |
News, Short Squeeze, Breakout and More Instantly...
GlaxoSmithKline PLC Company Name:
GSK Stock Symbol:
NYSE Market:
Wednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling Pounds), up 10% Y/Y and 13% e...
A negative sentiment might linger on Wall Street on Wednesday, as evidenced by stock futures, after Advanced Micro Devices, Inc.‘s (NASD...
Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...